首页 > 最新文献

Molecular Metabolism最新文献

英文 中文
Essential role of germ cell glycerol-3-phosphate phosphatase for sperm health, oxidative stress control and male fertility in mice 生殖细胞甘油-3-磷酸磷酸酶对小鼠精子健康、氧化应激控制和雄性生育能力的重要作用
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-13 DOI: 10.1016/j.molmet.2024.102063
Abel Oppong , Yat Hei Leung , Anindya Ghosh , Marie-Line Peyot , Marilène Paquet , Carlos Morales , Hugh J. Clarke , Fahd Al-Mulla , Alexandre Boyer , S. R. Murthy Madiraju , Derek Boerboom , Cristian O'Flaherty , Marc Prentki

Objectives

Obesity, diabetes and high-calorie diets are associated with defective sperm function and lowered male fertility. Mature spermatozoa primarily use fructose and glucose, and glucose and glycerol metabolism are important for sperm function. We recently discovered a novel mammalian enzyme, glycerol-3-phosphate (Gro3P) phosphatase (G3PP), and showed that it operates the glycerol shunt by hydrolyzing Gro3P to glycerol, and regulates glucose, lipid and energy metabolism in pancreatic β-cells and liver. We now observed that G3PP expression is the highest in the testis and spermatozoa, and investigated its role in male fertility.

Methods

We examined G3PP expression during spermatogenesis in mouse and assessed male fertility and spermatozoon function in conditional germ cell specific G3PP-KO (cG3PP-KO) mice and tamoxifen-inducible conditional germ cell G3PP-KO (icG3PP-KO) mice. We also determined the structural and metabolic parameters and oxidative stress in the spermatozoa from icG3PP-KO and control mice.

Results

G3PP expression in mouse spermatocytes and spermatids markedly increases during spermatogenesis. Male cG3PP-KO mice, in which germ cell G3PP is deleted from embryonic stage, are infertile due to dysfunctional sperm with reduced motility and capacitation, and elevated spontaneous acrosomal reaction and oxidative stress. However, icG3PP-KO male mice do not have altered fertility, due to the presence of ∼10% normal spermatozoa. icG3PP-KO spermatozoa display significantly reduced functionality and morphological and ultrastructural alterations. The icG3PP-KO spermatozoa show reduced glycerol production, elevated levels of Gro3P and reactive oxygen species (ROS), and oxidative stress that is associated with increased mitochondrial membrane potential.

Conclusions

Germ cell G3PP deletion leads to the generation of spermatozoa that are functionally and structurally abnormal, likely due to the build-up of Gro3P that increases mitochondrial membrane potential, ROS, and oxidative stress and alters spermatozoa function. Overall, the results indicate that G3PP and the glycerol shunt are essential for normal spermatozoa function and male fertility.
目的:肥胖、糖尿病和高热量饮食与精子功能缺陷和男性生育能力降低有关。成熟精子主要利用果糖和葡萄糖,葡萄糖和甘油代谢对精子功能非常重要。我们最近发现了一种新型哺乳动物酶--甘油-3-磷酸(Gro3P)磷酸酶(G3PP),并证明它通过将Gro3P水解为甘油来实现甘油分流,并调节胰腺β细胞和肝脏中的葡萄糖、脂质和能量代谢。现在,我们观察到 G3PP 在睾丸和精子中的表达量最高,并研究了它在男性生育中的作用:我们检测了小鼠精子发生过程中 G3PP 的表达,并评估了条件性生殖细胞特异性 G3PP-KO (cG3PP-KO)小鼠和他莫昔芬诱导的条件性生殖细胞 G3PP-KO (icG3PP-KO)小鼠的雄性生育能力和精子功能。我们还测定了icG3PP-KO和对照组小鼠精子的结构和代谢参数以及氧化应激:结果:在精子发生过程中,G3PP在小鼠精母细胞和精子中的表达明显增加。雄性 cG3PP-KO 小鼠的生殖细胞 G3PP 从胚胎阶段就被删除,由于精子功能障碍、运动能力和获能能力下降、自发顶体反应和氧化应激升高,导致不育。然而,icG3PP-KO 雄性小鼠由于存在 10%的正常精子,其生育能力并没有改变。icG3PP-KO精子的甘油生成减少,Gro3P和活性氧(ROS)水平升高,氧化应激与线粒体膜电位升高有关:结论:生殖细胞 G3PP 基因缺失会导致生成功能和结构异常的精子,这可能是由于 Gro3P 的积累增加了线粒体膜电位、ROS 和氧化应激,并改变了精子的功能。总之,研究结果表明,G3PP 和甘油分流对精子的正常功能和男性生育能力至关重要。
{"title":"Essential role of germ cell glycerol-3-phosphate phosphatase for sperm health, oxidative stress control and male fertility in mice","authors":"Abel Oppong ,&nbsp;Yat Hei Leung ,&nbsp;Anindya Ghosh ,&nbsp;Marie-Line Peyot ,&nbsp;Marilène Paquet ,&nbsp;Carlos Morales ,&nbsp;Hugh J. Clarke ,&nbsp;Fahd Al-Mulla ,&nbsp;Alexandre Boyer ,&nbsp;S. R. Murthy Madiraju ,&nbsp;Derek Boerboom ,&nbsp;Cristian O'Flaherty ,&nbsp;Marc Prentki","doi":"10.1016/j.molmet.2024.102063","DOIUrl":"10.1016/j.molmet.2024.102063","url":null,"abstract":"<div><h3>Objectives</h3><div>Obesity, diabetes and high-calorie diets are associated with defective sperm function and lowered male fertility. Mature spermatozoa primarily use fructose and glucose, and glucose and glycerol metabolism are important for sperm function. We recently discovered a novel mammalian enzyme, glycerol-3-phosphate (Gro3P) phosphatase (G3PP), and showed that it operates the glycerol shunt by hydrolyzing Gro3P to glycerol, and regulates glucose, lipid and energy metabolism in pancreatic β-cells and liver. We now observed that G3PP expression is the highest in the testis and spermatozoa, and investigated its role in male fertility.</div></div><div><h3>Methods</h3><div>We examined G3PP expression during spermatogenesis in mouse and assessed male fertility and spermatozoon function in conditional germ cell specific G3PP-KO (cG3PP-KO) mice and tamoxifen-inducible conditional germ cell G3PP-KO (icG3PP-KO) mice. We also determined the structural and metabolic parameters and oxidative stress in the spermatozoa from icG3PP-KO and control mice.</div></div><div><h3>Results</h3><div>G3PP expression in mouse spermatocytes and spermatids markedly increases during spermatogenesis. Male cG3PP-KO mice, in which germ cell G3PP is deleted from embryonic stage, are infertile due to dysfunctional sperm with reduced motility and capacitation, and elevated spontaneous acrosomal reaction and oxidative stress. However, icG3PP-KO male mice do not have altered fertility, due to the presence of ∼10% normal spermatozoa. icG3PP-KO spermatozoa display significantly reduced functionality and morphological and ultrastructural alterations. The icG3PP-KO spermatozoa show reduced glycerol production, elevated levels of Gro3P and reactive oxygen species (ROS), and oxidative stress that is associated with increased mitochondrial membrane potential.</div></div><div><h3>Conclusions</h3><div>Germ cell G3PP deletion leads to the generation of spermatozoa that are functionally and structurally abnormal, likely due to the build-up of Gro3P that increases mitochondrial membrane potential, ROS, and oxidative stress and alters spermatozoa function. Overall, the results indicate that G3PP and the glycerol shunt are essential for normal spermatozoa function and male fertility.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102063"},"PeriodicalIF":7.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased susceptibility to diet-induced obesity in female mice impairs ovarian steroidogenesis: The role of elevated leptin signalling on nodal activity inhibition in theca cells 雌性小鼠对饮食诱发肥胖的易感性增加会损害卵巢类固醇的生成:瘦素信号的升高对卵巢癌细胞中 Nodal 活性抑制的作用。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-12 DOI: 10.1016/j.molmet.2024.102062
Karolina Wołodko , Tjaša Šentjurc , Edyta Walewska , Elżbieta Laniecka , Magdalena Jura , António Galvão
<div><h3>Objectives</h3><div>Susceptibility to obesity in humans is driven by the intricate interplay of genetic, environmental and behavioural factors. Moreover, the mechanisms linking maternal obesity to infertility remain largely understudied. In this study, we investigated how variable susceptibility to obesity in mice affects ovarian steroidogenesis, with a particular focus on the leptin-mediated dysregulation of Nodal signalling pathway in theca cells (TC).</div></div><div><h3>Methods</h3><div>C56BL/6J (B6) and 129S1/SvlmJ (129) mice, models of maternal obesity (MO), were fed a chow diet (CD) and a high fat diet (HFD) for 16 weeks. To investigate the contrasting effects of leptin on ovarian steroidogenesis, B6 mice pharmacologically treated with leptin for 16 days on CD were used to model hyperleptinemia, while homozygous ob/ob (−/−) mice with genetic leptin deficiency, also on a CD, were used to examine the effects of obesity in the absence of leptin. Following the characterisation of the mouse phenotype, gonadal fat (GON), whole ovaries (WO), ovarian TC and granulosa cell (GC) fractions were collected for mRNA transcription and protein expression analysis. Finally, <em>in vitro</em> treated ovarian explants obtained from B6 mice were used to further elucidate the effects of Nodal on steroidogenesis.</div></div><div><h3>Results</h3><div>The significant gain in body weight (BW) and fat mass (FM) in HFD-fed B6 mice (p < 0.05), was associated with increased mRNA transcription of the adipose tissue expansion genes <em>Polymerase I and transcript release factor</em> (<em>Cavin</em>), <em>Secreted frizzled-related protein 5</em> (<em>Sfrp5</em>) and <em>Mesoderm specific transcript</em> (<em>Mest</em>) in GON (p < 0.05). Furthermore, the HFD-fed B6 mice presented also impaired glucose metabolism and insulin sensitivity (p < 0.05). In contrast, the HFD-fed 129 mice exhibited no changes in BW and FM, maintaining glucose and insulin metabolism. At the ovarian level, decreased protein expression of Steroidogenic Acute Regulatory Protein (StAR) in WO obtained from HFD-fed B6 mice (p = 0.05), was followed by reduced transcription of key steroidogenic genes like <em>Star</em> and <em>Cytochrome P450 17a1</em> (<em>Cyp17a</em>) in TC (p < 0.05). Furthermore, the transcription of <em>Nodal</em> and its receptors was downregulated (p < 0.05), whereas mRNA levels of <em>Suppressor of cytokine signalling 3 (Socs3)</em> and <em>SMAD family member 7 (Smad7)</em> were upregulated in TC obtained from HFD-fed B6 mice (p < 0.05). No changes were seen in the genes regulating steroidogenesis, Nodal signalling, or <em>Socs3</em> and <em>Smad7</em> activity in the ovaries of HFD-fed 129 mice. Importantly, the pharmacological treatment of lean mice with leptin, upregulated the ovarian transcription of <em>Socs3</em> and <em>Smad7</em>, while downregulating <em>Nodal</em> and its receptors (p < 0.05). Finally, <em>in vitro</em> pharmacological inhi
目的:人类的肥胖易感性是由错综复杂的遗传、环境和行为因素相互作用造成的。此外,孕产妇肥胖与不孕症之间的关联机制在很大程度上仍未得到充分研究。在这项研究中,我们调查了小鼠对肥胖的易感性如何影响卵巢类固醇的生成,尤其关注瘦素介导的卵巢癌细胞(TC)Nodal 信号通路的失调:方法:C56BL/6J(B6)和129S1/SvlmJ(129)小鼠是母体肥胖(MO)的模型,它们分别被喂食低脂饮食(CD)和高脂饮食(HFD)16周。为了研究瘦素对卵巢类固醇生成的不同影响,我们用瘦素药理治疗16天的B6小鼠来模拟高瘦素血症,同时用遗传性瘦素缺乏的同基因ob/ob (-/-)小鼠来研究缺乏瘦素时肥胖的影响。在确定小鼠的表型特征后,收集了性腺脂肪(GON)、整个卵巢(WO)、卵巢TC和颗粒细胞(GC)部分进行mRNA转录和蛋白质表达分析。最后,用体外处理的 B6 小鼠卵巢外植体进一步阐明 Nodal 对类固醇生成的影响:结果:HFD喂养的B6小鼠体重(BW)和脂肪量(FM)明显增加(p结论:Nodal对肥胖的易感性增加:MO肥胖易感性的增加与全身性高瘦素血症和卵巢类固醇生成受损导致的雌激素过低有关,这主要是由瘦素-Smad7通路对卵巢卵泡TC区Nodal信号活性的抑制作用驱动的。
{"title":"Increased susceptibility to diet-induced obesity in female mice impairs ovarian steroidogenesis: The role of elevated leptin signalling on nodal activity inhibition in theca cells","authors":"Karolina Wołodko ,&nbsp;Tjaša Šentjurc ,&nbsp;Edyta Walewska ,&nbsp;Elżbieta Laniecka ,&nbsp;Magdalena Jura ,&nbsp;António Galvão","doi":"10.1016/j.molmet.2024.102062","DOIUrl":"10.1016/j.molmet.2024.102062","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objectives&lt;/h3&gt;&lt;div&gt;Susceptibility to obesity in humans is driven by the intricate interplay of genetic, environmental and behavioural factors. Moreover, the mechanisms linking maternal obesity to infertility remain largely understudied. In this study, we investigated how variable susceptibility to obesity in mice affects ovarian steroidogenesis, with a particular focus on the leptin-mediated dysregulation of Nodal signalling pathway in theca cells (TC).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;C56BL/6J (B6) and 129S1/SvlmJ (129) mice, models of maternal obesity (MO), were fed a chow diet (CD) and a high fat diet (HFD) for 16 weeks. To investigate the contrasting effects of leptin on ovarian steroidogenesis, B6 mice pharmacologically treated with leptin for 16 days on CD were used to model hyperleptinemia, while homozygous ob/ob (−/−) mice with genetic leptin deficiency, also on a CD, were used to examine the effects of obesity in the absence of leptin. Following the characterisation of the mouse phenotype, gonadal fat (GON), whole ovaries (WO), ovarian TC and granulosa cell (GC) fractions were collected for mRNA transcription and protein expression analysis. Finally, &lt;em&gt;in vitro&lt;/em&gt; treated ovarian explants obtained from B6 mice were used to further elucidate the effects of Nodal on steroidogenesis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The significant gain in body weight (BW) and fat mass (FM) in HFD-fed B6 mice (p &lt; 0.05), was associated with increased mRNA transcription of the adipose tissue expansion genes &lt;em&gt;Polymerase I and transcript release factor&lt;/em&gt; (&lt;em&gt;Cavin&lt;/em&gt;), &lt;em&gt;Secreted frizzled-related protein 5&lt;/em&gt; (&lt;em&gt;Sfrp5&lt;/em&gt;) and &lt;em&gt;Mesoderm specific transcript&lt;/em&gt; (&lt;em&gt;Mest&lt;/em&gt;) in GON (p &lt; 0.05). Furthermore, the HFD-fed B6 mice presented also impaired glucose metabolism and insulin sensitivity (p &lt; 0.05). In contrast, the HFD-fed 129 mice exhibited no changes in BW and FM, maintaining glucose and insulin metabolism. At the ovarian level, decreased protein expression of Steroidogenic Acute Regulatory Protein (StAR) in WO obtained from HFD-fed B6 mice (p = 0.05), was followed by reduced transcription of key steroidogenic genes like &lt;em&gt;Star&lt;/em&gt; and &lt;em&gt;Cytochrome P450 17a1&lt;/em&gt; (&lt;em&gt;Cyp17a&lt;/em&gt;) in TC (p &lt; 0.05). Furthermore, the transcription of &lt;em&gt;Nodal&lt;/em&gt; and its receptors was downregulated (p &lt; 0.05), whereas mRNA levels of &lt;em&gt;Suppressor of cytokine signalling 3 (Socs3)&lt;/em&gt; and &lt;em&gt;SMAD family member 7 (Smad7)&lt;/em&gt; were upregulated in TC obtained from HFD-fed B6 mice (p &lt; 0.05). No changes were seen in the genes regulating steroidogenesis, Nodal signalling, or &lt;em&gt;Socs3&lt;/em&gt; and &lt;em&gt;Smad7&lt;/em&gt; activity in the ovaries of HFD-fed 129 mice. Importantly, the pharmacological treatment of lean mice with leptin, upregulated the ovarian transcription of &lt;em&gt;Socs3&lt;/em&gt; and &lt;em&gt;Smad7&lt;/em&gt;, while downregulating &lt;em&gt;Nodal&lt;/em&gt; and its receptors (p &lt; 0.05). Finally, &lt;em&gt;in vitro&lt;/em&gt; pharmacological inhi","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"91 ","pages":"Article 102062"},"PeriodicalIF":7.0,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variable glucagon metabolic actions in diverse mouse models of obesity and type 2 diabetes 胰高血糖素在不同肥胖症和 2 型糖尿病小鼠模型中的代谢作用各不相同。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-12 DOI: 10.1016/j.molmet.2024.102064
Yuqin Wu , Andrea Y. Chan , Jana Hauke , Okka Htin Aung , Ashish Foollee , Maria Almira S. Cleofe , Helen Stölting , Mei-Ling Han , Katherine J. Jeppe , Christopher K. Barlow , Jürgen G. Okun , Patricia M. Rusu , Adam J. Rose

Objective

The study aimed to investigate the effects of glucagon on metabolic pathways in mouse models of obesity, fatty liver disease, and type 2 diabetes (T2D) to determine the extent and variability of hepatic glucagon resistance in these conditions.

Methods

We investigated glucagon's effects in mouse models of fatty liver disease, obesity, and type 2 diabetes (T2D), including male BKS-db/db, high-fat diet-fed, and western diet-fed C57Bl/6 mice. Glucagon tolerance tests were performed using the selective glucagon receptor agonist acyl-glucagon (IUB288). Blood glucose, serum and liver metabolites include lipids and amino acids were measured. Additionally, liver protein expression related to glucagon signalling and a comprehensive liver metabolomics were performed.

Results

Western diet-fed mice displayed impaired glucagon response, with reduced blood glucose and PKA activation. In contrast, high-fat diet-fed and db/db mice maintained normal glucagon sensitivity, showing significant elevations in blood glucose and phospho-PKA motif protein expression. Acyl-glucagon treatment also lowered liver alanine and histidine levels in high-fat diet-fed mice, but not in western diet-fed mice. Additionally, some amino acids, such as methionine, were increased by acyl-glucagon only in chow diet control mice. Despite normal glucagon sensitivity in PKA signalling, db/db mice had a distinct metabolomic response, with acyl-glucagon significantly altering 90 metabolites in db/+ mice but only 42 in db/db mice, and classic glucagon-regulated metabolites, such as cyclic adenosine monophosphate (cAMP), being less responsive in db/db mice.

Conclusions

The study reveals that hepatic glucagon resistance in obesity and T2D is complex and not uniform across metabolic pathways, underscoring the complexity of glucagon action in these conditions.
研究目的本研究旨在调查胰高血糖素对肥胖、脂肪肝和2型糖尿病(T2D)小鼠模型代谢途径的影响,以确定在这些情况下肝脏胰高血糖素抵抗的程度和可变性:我们研究了胰高血糖素对脂肪肝、肥胖和2型糖尿病(T2D)小鼠模型的影响,包括雄性BKS-db/db、高脂饮食喂养和西式饮食喂养的C57Bl/6小鼠。使用选择性胰高血糖素受体激动剂酰基胰高血糖素(IUB288)进行胰高血糖素耐受试验。对血糖、血清和肝脏代谢物(包括脂类和氨基酸)进行了测定。此外,还进行了与胰高血糖素信号相关的肝脏蛋白质表达和全面的肝脏代谢组学研究:结果:西式饮食喂养的小鼠显示出胰高血糖素反应受损,血糖降低,PKA活化。相比之下,高脂饮食喂养的小鼠和 db/db 小鼠对胰高血糖素的敏感性保持正常,血糖和磷酸-PKA 矩阵蛋白表达显著升高。酰基胰高血糖素处理还能降低高脂饮食喂养小鼠肝脏丙氨酸和组氨酸的水平,但不能降低西式饮食喂养小鼠肝脏丙氨酸和组氨酸的水平。此外,酰基胰高血糖素还能增加某些氨基酸的含量,如蛋氨酸,但只有在低脂饮食对照组小鼠中才会出现这种情况。尽管胰高血糖素对PKA信号的敏感性正常,但db/db小鼠的代谢组学反应却截然不同,酰基胰高血糖素可显著改变db/+小鼠的90种代谢物,但在db/db小鼠中仅有42种代谢物发生了改变,而胰高血糖素调节的典型代谢物,如环磷酸腺苷(cAMP),在db/db小鼠中反应较小:结论:该研究揭示了肥胖症和T2D的肝脏胰高血糖素抵抗是复杂的,而且在不同的代谢途径中并不一致,这凸显了胰高血糖素在这些情况下作用的复杂性。
{"title":"Variable glucagon metabolic actions in diverse mouse models of obesity and type 2 diabetes","authors":"Yuqin Wu ,&nbsp;Andrea Y. Chan ,&nbsp;Jana Hauke ,&nbsp;Okka Htin Aung ,&nbsp;Ashish Foollee ,&nbsp;Maria Almira S. Cleofe ,&nbsp;Helen Stölting ,&nbsp;Mei-Ling Han ,&nbsp;Katherine J. Jeppe ,&nbsp;Christopher K. Barlow ,&nbsp;Jürgen G. Okun ,&nbsp;Patricia M. Rusu ,&nbsp;Adam J. Rose","doi":"10.1016/j.molmet.2024.102064","DOIUrl":"10.1016/j.molmet.2024.102064","url":null,"abstract":"<div><h3>Objective</h3><div>The study aimed to investigate the effects of glucagon on metabolic pathways in mouse models of obesity, fatty liver disease, and type 2 diabetes (T2D) to determine the extent and variability of hepatic glucagon resistance in these conditions.</div></div><div><h3>Methods</h3><div>We investigated glucagon's effects in mouse models of fatty liver disease, obesity, and type 2 diabetes (T2D), including male BKS-db/db, high-fat diet-fed, and western diet-fed C57Bl/6 mice. Glucagon tolerance tests were performed using the selective glucagon receptor agonist acyl-glucagon (IUB288). Blood glucose, serum and liver metabolites include lipids and amino acids were measured. Additionally, liver protein expression related to glucagon signalling and a comprehensive liver metabolomics were performed.</div></div><div><h3>Results</h3><div>Western diet-fed mice displayed impaired glucagon response, with reduced blood glucose and PKA activation. In contrast, high-fat diet-fed and db/db mice maintained normal glucagon sensitivity, showing significant elevations in blood glucose and phospho-PKA motif protein expression. Acyl-glucagon treatment also lowered liver alanine and histidine levels in high-fat diet-fed mice, but not in western diet-fed mice. Additionally, some amino acids, such as methionine, were increased by acyl-glucagon only in chow diet control mice. Despite normal glucagon sensitivity in PKA signalling, db/db mice had a distinct metabolomic response, with acyl-glucagon significantly altering 90 metabolites in db/+ mice but only 42 in db/db mice, and classic glucagon-regulated metabolites, such as cyclic adenosine monophosphate (cAMP), being less responsive in db/db mice.</div></div><div><h3>Conclusions</h3><div>The study reveals that hepatic glucagon resistance in obesity and T2D is complex and not uniform across metabolic pathways, underscoring the complexity of glucagon action in these conditions.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102064"},"PeriodicalIF":7.0,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time-restricted feeding prevents memory impairments induced by obesogenic diet consumption, via hippocampal thyroid hormone signaling 限时进食可通过海马甲状腺激素信号传导预防肥胖饮食引起的记忆损伤。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-06 DOI: 10.1016/j.molmet.2024.102061
Jean-Christophe Helbling , Rachel Ginieis , Pierre Mortessagne , Mariano Ruiz-Gayo , Ioannis Bakoyiannis , Eva-Gunnel Ducourneau , Dominique Ciocca , Illona-Marie Bouleté , Alexandre Favereaux , Aurélia Ces , Enrica Montalban , Lucile Capuron , Freddy Jeanneteau , Guillaume Ferreira , Etienne Challet , Marie-Pierre Moisan

Objective

The early consumption of calorie-rich diet disrupts circadian rhythms and has adverse effects on memory, yet the effects of time-restricted feeding (TRF) and the underlying molecular mechanisms are unknown. Here, we set out to identify the behavioral and molecular circadian rhythms disruptions generated by juvenile obesogenic diet consumption and their restoration by TRF in male mice.

Methods

Metabolic rhythms were measured by indirect calorimetry and memory performances by behavioral tasks. Hippocampal translatome (pS6_TRAP), enrichment and co-regulated gene network analyses were conducted to identify the molecular pathways involved in memory impairments and their restoration by TRF. Differential exon usage analyses, mass spectrometry and pharmacological intervention were used to confirm thyroid hormone signaling involvement.

Results

We show that four weeks of TRF restore the rhythmicity of metabolic parameters and prevents memory impairments in mice fed a high fat-high sucrose (HFS) diet since weaning, independently of body fat levels. Hippocampal translatome and differential exon usage analyses indicate that impaired memory of mice under ad libitum HFS diet is accompanied by reduced thyroid hormone signaling and altered expression of astrocytic genes regulating glutamate neurotransmission. TRF restored the diurnal expression variation of part of these genes and intra-hippocampal infusion of T3, the active form of thyroid hormone, rescues memory performances and astrocytic gene expression of ad libitum HFS diet-fed mice.

Conclusions

Thus, thyroid hormones contribute to the TRF positive effects on both metabolism and memory in mice fed an obesogenic diet, highlighting this nutritional approach as a powerful tool in addressing obesity brain comorbidities and paving the way for further mechanistic studies on hippocampal thyroid signaling.
目的:早期摄入高热量饮食会扰乱昼夜节律并对记忆产生不利影响,但限时喂养(TRF)的影响及其潜在的分子机制尚不清楚。在此,我们试图确定幼年肥胖饮食对雄性小鼠行为和分子昼夜节律的干扰,以及通过TRF恢复这些干扰:方法:代谢节律通过间接热量计测量,记忆表现通过行为任务测量。方法:通过间接热量计测量代谢节律,通过行为任务测量记忆表现,进行海马转译组(pS6_TRAP)、富集和共调基因网络分析,以确定参与记忆损伤的分子通路,以及通过TRF恢复记忆的分子通路。差异外显子使用分析、质谱分析和药物干预被用来证实甲状腺激素信号的参与:结果:我们发现,对自断奶起就以高脂肪-高蔗糖(HFS)饮食喂养的小鼠来说,四周的TRF可恢复代谢参数的节律性并防止记忆损伤,而与体脂水平无关。海马转位组和差异外显子使用分析表明,小鼠在自由摄入高脂高蔗糖饮食的情况下记忆力受损,与甲状腺激素信号传导减少和调节谷氨酸神经传导的星形胶质细胞基因表达改变有关。TRF可恢复这些基因中部分基因的昼夜表达变化,而在海马内注入甲状腺激素的活性形式T3,可挽救自由摄入HFS饮食的小鼠的记忆表现和星形胶质细胞基因表达:因此,甲状腺激素有助于TRF对肥胖饮食喂养小鼠的新陈代谢和记忆力产生积极影响,凸显了这种营养方法是解决肥胖脑合并症的有力工具,并为进一步开展海马甲状腺信号转导的机理研究铺平了道路。
{"title":"Time-restricted feeding prevents memory impairments induced by obesogenic diet consumption, via hippocampal thyroid hormone signaling","authors":"Jean-Christophe Helbling ,&nbsp;Rachel Ginieis ,&nbsp;Pierre Mortessagne ,&nbsp;Mariano Ruiz-Gayo ,&nbsp;Ioannis Bakoyiannis ,&nbsp;Eva-Gunnel Ducourneau ,&nbsp;Dominique Ciocca ,&nbsp;Illona-Marie Bouleté ,&nbsp;Alexandre Favereaux ,&nbsp;Aurélia Ces ,&nbsp;Enrica Montalban ,&nbsp;Lucile Capuron ,&nbsp;Freddy Jeanneteau ,&nbsp;Guillaume Ferreira ,&nbsp;Etienne Challet ,&nbsp;Marie-Pierre Moisan","doi":"10.1016/j.molmet.2024.102061","DOIUrl":"10.1016/j.molmet.2024.102061","url":null,"abstract":"<div><h3>Objective</h3><div>The early consumption of calorie-rich diet disrupts circadian rhythms and has adverse effects on memory, yet the effects of time-restricted feeding (TRF) and the underlying molecular mechanisms are unknown. Here, we set out to identify the behavioral and molecular circadian rhythms disruptions generated by juvenile obesogenic diet consumption and their restoration by TRF in male mice.</div></div><div><h3>Methods</h3><div>Metabolic rhythms were measured by indirect calorimetry and memory performances by behavioral tasks. Hippocampal translatome (pS6_TRAP), enrichment and co-regulated gene network analyses were conducted to identify the molecular pathways involved in memory impairments and their restoration by TRF. Differential exon usage analyses, mass spectrometry and pharmacological intervention were used to confirm thyroid hormone signaling involvement.</div></div><div><h3>Results</h3><div>We show that four weeks of TRF restore the rhythmicity of metabolic parameters and prevents memory impairments in mice fed a high fat-high sucrose (HFS) diet since weaning, independently of body fat levels. Hippocampal translatome and differential exon usage analyses indicate that impaired memory of mice under <em>ad libitum</em> HFS diet is accompanied by reduced thyroid hormone signaling and altered expression of astrocytic genes regulating glutamate neurotransmission. TRF restored the diurnal expression variation of part of these genes and intra-hippocampal infusion of T3, the active form of thyroid hormone, rescues memory performances and astrocytic gene expression of <em>ad libitum</em> HFS diet-fed mice.</div></div><div><h3>Conclusions</h3><div>Thus, thyroid hormones contribute to the TRF positive effects on both metabolism and memory in mice fed an obesogenic diet, highlighting this nutritional approach as a powerful tool in addressing obesity brain comorbidities and paving the way for further mechanistic studies on hippocampal thyroid signaling.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102061"},"PeriodicalIF":7.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease GLIS3:出生后肾脏和多囊肾病中线粒体功能和代谢重编程的新型转录调节因子。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-05 DOI: 10.1016/j.molmet.2024.102052
Justin B. Collier , Hong Soon Kang , Yun-Gil Roh , Chitrangda Srivastava , Sara A. Grimm , Alan K. Jarmusch , Anton M. Jetten

Objectives

Deficiency in the transcription factor (TF) GLI-Similar 3 (GLIS3) in humans and mice leads to the development of polycystic kidney disease (PKD). In this study, we investigate the role of GLIS3 in the regulation of energy metabolism and mitochondrial functions in relation to its role in normal kidney and metabolic reprogramming in PKD pathogenesis.

Methods

Transcriptomics, cistromics, and metabolomics were used to obtain insights into the role of GLIS3 in the regulation of energy homeostasis and mitochondrial metabolism in normal kidney and PKD pathogenesis using GLIS3-deficient mice.

Results

Transcriptome analysis showed that many genes critical for mitochondrial biogenesis, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and the tricarboxylic acid (TCA) cycle, including Tfam, Tfb1m, Tfb2m, Ppargc1a, Ppargc1b, Atp5j2, Hadha, and Sdha, are significantly suppressed in kidneys from both ubiquitous and tissue-specific Glis3-deficient mice. ChIP-Seq analysis demonstrated that GLIS3 is associated with the regulatory region of many of these genes, indicating that their transcription is directly regulated by GLIS3. Cistrome analyses revealed that GLIS3 binding loci frequently located near those of hepatocyte nuclear factor 1-Beta (HNF1B) and nuclear respiratory factor 1 (NRF1) suggesting GLIS3 regulates transcription of many metabolic and mitochondrial function-related genes in coordination with these TFs. Seahorse analysis and untargeted metabolomics corroborated that mitochondrial OXPHOS utilization is suppressed in GLIS3-deficient kidneys and showed that key metabolites in glycolysis, TCA cycle, and glutamine pathways were altered indicating increased reliance on aerobic glycolysis and glutamine anaplerosis. These features of metabolic reprogramming may contribute to a bioenergetic environment that supports renal cyst formation and progression in Glis3-deficient mice kidneys.

Conclusions

We identify GLIS3 as a novel positive regulator of the transition from aerobic glycolysis to OXPHOS in normal early postnatal kidney development by directly regulating the transcription of mitochondrial metabolic genes. Loss of GLIS3 induces several features of renal cell metabolic reprogramming. Our study identifies GLIS3 as a new participant in an interconnected transcription regulatory network, that includes HNF1B and NRF1, critical in the regulation of mitochondrial-related gene expression and energy metabolism in normal postnatal kidneys and PKD pathogenesis in Glis3-deficient mice.
背景和目的:人类和小鼠体内转录因子(TF)GLI-相似3(GLIS3)的缺陷会导致多囊肾病(PKD)的发生。在这项研究中,我们研究了GLIS3在能量代谢和线粒体功能调控中的作用,以及它在正常肾脏中的作用和在PKD发病机制中的代谢重编程:利用转录组学、表观组学和代谢组学,通过GLIS3缺陷小鼠深入了解GLIS3在正常肾脏和PKD发病机制中调控能量平衡和线粒体代谢的作用。转录组分析表明,许多对线粒体生物生成、氧化磷酸化(OXPHOS)、脂肪酸氧化(FAO)和三羧酸(TCA)循环至关重要的基因,包括Tfam、Tfb1m、Tfb2m、Ppargc1a、Ppargc1b、Atp5j2、Hadha和Sdha,在无处不在的和组织特异性Glis3缺陷小鼠的肾脏中都受到显著抑制。ChIP-Seq 分析表明,GLIS3 与这些基因中的许多基因的调控区相关,表明它们的转录直接受 GLIS3 的调控。Cistrome分析表明,GLIS3的结合位点经常位于肝细胞核因子1-Beta(HNF1B)和核呼吸因子1(NRF1)的结合位点附近,这表明GLIS3与这些TFs共同调控许多代谢和线粒体功能相关基因的转录。海马分析和非靶向代谢组学证实,线粒体 OXPHOS 的利用在 GLIS3 基因缺陷的肾脏中受到抑制,并表明糖酵解、TCA 循环和谷氨酰胺途径中的关键代谢物发生了改变,这表明对有氧糖酵解和谷氨酰胺合成的依赖性增加。代谢重编程的这些特征可能有助于形成一种生物能环境,支持 Glis3 缺陷小鼠肾囊肿的形成和发展:我们发现 GLIS3 是一种新型的正向调控因子,它通过直接调控线粒体代谢基因的转录,在正常的出生后早期肾脏发育过程中从有氧糖酵解向 OXPHOS 过渡。缺失 GLIS3 会诱导肾细胞代谢重编程的几个特征。我们的研究发现,GLIS3是一个相互关联的转录调控网络的新参与者,该网络包括HNF1B和NRF1,在正常出生后肾脏线粒体相关基因表达和能量代谢以及Glis3缺陷小鼠PKD发病机制的调控中起着关键作用。
{"title":"GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease","authors":"Justin B. Collier ,&nbsp;Hong Soon Kang ,&nbsp;Yun-Gil Roh ,&nbsp;Chitrangda Srivastava ,&nbsp;Sara A. Grimm ,&nbsp;Alan K. Jarmusch ,&nbsp;Anton M. Jetten","doi":"10.1016/j.molmet.2024.102052","DOIUrl":"10.1016/j.molmet.2024.102052","url":null,"abstract":"<div><h3><strong>Objectives</strong></h3><div>Deficiency in the transcription factor (TF) GLI-Similar 3 (GLIS3) in humans and mice leads to the development of polycystic kidney disease (PKD). In this study, we investigate the role of GLIS3 in the regulation of energy metabolism and mitochondrial functions in relation to its role in normal kidney and metabolic reprogramming in PKD pathogenesis.</div></div><div><h3>Methods</h3><div>Transcriptomics, cistromics, and metabolomics were used to obtain insights into the role of GLIS3 in the regulation of energy homeostasis and mitochondrial metabolism in normal kidney and PKD pathogenesis using GLIS3-deficient mice.</div></div><div><h3>Results</h3><div>Transcriptome analysis showed that many genes critical for mitochondrial biogenesis, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and the tricarboxylic acid (TCA) cycle, including <em>Tfam</em>, <em>Tfb1m</em>, <em>Tfb2m</em>, <em>Ppargc1a</em>, <em>Ppargc1b, Atp5j2</em>, <em>Hadha</em>, and <em>Sdha,</em> are significantly suppressed in kidneys from both ubiquitous and tissue-specific <em>Glis3-</em>deficient mice. ChIP-Seq analysis demonstrated that GLIS3 is associated with the regulatory region of many of these genes, indicating that their transcription is directly regulated by GLIS3. Cistrome analyses revealed that GLIS3 binding loci frequently located near those of hepatocyte nuclear factor 1-Beta (HNF1B) and nuclear respiratory factor 1 (NRF1) suggesting GLIS3 regulates transcription of many metabolic and mitochondrial function-related genes in coordination with these TFs. Seahorse analysis and untargeted metabolomics corroborated that mitochondrial OXPHOS utilization is suppressed in GLIS3-deficient kidneys and showed that key metabolites in glycolysis, TCA cycle, and glutamine pathways were altered indicating increased reliance on aerobic glycolysis and glutamine anaplerosis. These features of metabolic reprogramming may contribute to a bioenergetic environment that supports renal cyst formation and progression in <em>Glis3</em>-deficient mice kidneys.</div></div><div><h3>Conclusions</h3><div>We identify GLIS3 as a novel positive regulator of the transition from aerobic glycolysis to OXPHOS in normal early postnatal kidney development by directly regulating the transcription of mitochondrial metabolic genes. Loss of GLIS3 induces several features of renal cell metabolic reprogramming. Our study identifies GLIS3 as a new participant in an interconnected transcription regulatory network, that includes HNF1B and NRF1, critical in the regulation of mitochondrial-related gene expression and energy metabolism in normal postnatal kidneys and PKD pathogenesis in <em>Glis3</em>-deficient mice.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102052"},"PeriodicalIF":7.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway TOMM40 通过 LXR 依赖性途径调节肝细胞和血浆脂质代谢。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-01 DOI: 10.1016/j.molmet.2024.102056
Neil V. Yang , Justin Y. Chao , Kelly A. Garton , Tommy Tran , Sarah M. King , Joseph Orr , Jacob H. Oei , Alexandra Crawford , Misun Kang , Reena Zalpuri , Danielle M. Jorgens , Pranav Konchadi , John S. Chorba , Elizabeth Theusch , Ronald M. Krauss

Objective

The gene encoding TOMM40 (Transporter of Outer Mitochondrial Membrane 40) is adjacent to that encoding APOE, which has a central role in lipid and lipoprotein metabolism. While human genetic variants near APOE and TOMM40 have been shown to be strongly associated with plasma lipid levels, a specific role for TOMM40 in lipid metabolism has not been established, and the present study was aimed at assessing this possibility.

Methods

TOMM40 was knocked down by siRNA in human hepatoma HepG2 cells, and effects on mitochondrial function, lipid phenotypes, and crosstalk between mitochondria, ER, and lipid droplets were examined. Additionally, hepatic and plasma lipid levels were measured in mice following shRNA-induced knockdown of Tomm40 shRNA.

Results

In HepG2 cells, TOMM40 knockdown upregulated expression of APOE and LDLR in part via activation of LXRB (NR1H2) by oxysterols, with consequent increased uptake of VLDL and LDL. This is in part due to disruption of mitochondria-endoplasmic reticulum contact sites, with resulting accrual of reactive oxygen species and non-enzymatically derived oxysterols. With TOMM40 knockdown, cellular triglyceride and lipid droplet content were increased, effects attributable in part to receptor-mediated VLDL uptake, since lipid staining was significantly reduced by concomitant suppression of either LDLR or APOE. In contrast, cellular cholesterol content was reduced due to LXRB-mediated upregulation of the ABCA1 transporter as well as increased production and secretion of oxysterol-derived cholic acid. Consistent with the findings in hepatoma cells, in vivo knockdown of TOMM40 in mice resulted in significant reductions of plasma triglyceride and cholesterol concentrations, reduced hepatic cholesterol and increased triglyceride content, and accumulation of lipid droplets leading to development of steatosis.

Conclusions

These findings demonstrate a role for TOMM40 in regulating hepatic lipid and plasma lipoprotein levels and identify mechanisms linking mitochondrial function with lipid metabolism.
编码 TOMM40(线粒体外膜转运体 40)的基因与编码 APOE 的基因相邻,而 APOE 在脂质和脂蛋白代谢中起着核心作用。APOE 和 TOMM40 附近的人类基因变异与血浆脂质水平密切相关,但 TOMM40 在脂质代谢中的具体作用尚未确定。我们在此表明,抑制人肝癌细胞中的 TOMM40 会上调 APOE 和 LDLR 的表达,部分原因是氧杂醇激活了 LXRB (NR1H2),从而增加了对 VLDL 和 LDL 的吸收。这在一定程度上是由于线粒体-内质网接触点被破坏,导致活性氧和非酶促氧固醇的累积。敲除 TOMM40 后,细胞甘油三酯和脂滴含量增加,这种效应部分归因于受体介导的 VLDL 吸收,因为同时抑制 LDLR 或 APOE 会显著减少脂质染色。相反,由于 LXRB 介导的 ABCA1 转运体上调以及源于氧固醇的胆酸的产生和分泌增加,细胞胆固醇含量降低。与肝癌细胞中的研究结果一致,在小鼠体内敲除 TOMM40 会导致血浆甘油三酯和胆固醇浓度显著降低、肝脏胆固醇减少和甘油三酯含量增加,以及导致脂肪变性的脂滴积累。这些发现证明了 TOMM40 在调节肝脏脂质和血浆脂蛋白水平中的作用,并确定了线粒体功能与脂质代谢的联系机制。
{"title":"TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway","authors":"Neil V. Yang ,&nbsp;Justin Y. Chao ,&nbsp;Kelly A. Garton ,&nbsp;Tommy Tran ,&nbsp;Sarah M. King ,&nbsp;Joseph Orr ,&nbsp;Jacob H. Oei ,&nbsp;Alexandra Crawford ,&nbsp;Misun Kang ,&nbsp;Reena Zalpuri ,&nbsp;Danielle M. Jorgens ,&nbsp;Pranav Konchadi ,&nbsp;John S. Chorba ,&nbsp;Elizabeth Theusch ,&nbsp;Ronald M. Krauss","doi":"10.1016/j.molmet.2024.102056","DOIUrl":"10.1016/j.molmet.2024.102056","url":null,"abstract":"<div><h3>Objective</h3><div>The gene encoding TOMM40 (Transporter of Outer Mitochondrial Membrane 40) is adjacent to that encoding APOE, which has a central role in lipid and lipoprotein metabolism. While human genetic variants near <em>APOE</em> and <em>TOMM40</em> have been shown to be strongly associated with plasma lipid levels, a specific role for TOMM40 in lipid metabolism has not been established, and the present study was aimed at assessing this possibility.</div></div><div><h3>Methods</h3><div><em>TOMM40</em> was knocked down by siRNA in human hepatoma HepG2 cells, and effects on mitochondrial function, lipid phenotypes, and crosstalk between mitochondria, ER, and lipid droplets were examined. Additionally, hepatic and plasma lipid levels were measured in mice following shRNA-induced knockdown of <em>Tomm40</em> shRNA.</div></div><div><h3>Results</h3><div>In HepG2 cells, <em>TOMM40</em> knockdown upregulated expression of <em>APOE</em> and <em>LDLR</em> in part via activation of LXRB (NR1H2) by oxysterols, with consequent increased uptake of VLDL and LDL. This is in part due to disruption of mitochondria-endoplasmic reticulum contact sites, with resulting accrual of reactive oxygen species and non-enzymatically derived oxysterols. With <em>TOMM40</em> knockdown, cellular triglyceride and lipid droplet content were increased, effects attributable in part to receptor-mediated VLDL uptake, since lipid staining was significantly reduced by concomitant suppression of either <em>LDLR</em> or <em>APOE</em>. In contrast, cellular cholesterol content was reduced due to LXRB-mediated upregulation of the ABCA1 transporter as well as increased production and secretion of oxysterol-derived cholic acid. Consistent with the findings in hepatoma cells, <em>in vivo</em> knockdown of <em>TOMM40</em> in mice resulted in significant reductions of plasma triglyceride and cholesterol concentrations, reduced hepatic cholesterol and increased triglyceride content, and accumulation of lipid droplets leading to development of steatosis.</div></div><div><h3>Conclusions</h3><div>These findings demonstrate a role for TOMM40 in regulating hepatic lipid and plasma lipoprotein levels and identify mechanisms linking mitochondrial function with lipid metabolism.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102056"},"PeriodicalIF":7.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-dose valine attenuates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) in mice by enhancing leptin sensitivity and modulating the gut microbiome 低剂量缬氨酸通过提高瘦素敏感性和调节肠道微生物组减轻饮食诱发的小鼠代谢功能障碍相关性脂肪肝(MASLD)。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-01 DOI: 10.1016/j.molmet.2024.102059
Felicianna , Emily K.K. Lo , Congjia Chen , Marsena J. Ismaiah , Fangfei Zhang , Hoi Kit Matthew Leung , Hani El-Nezami

Objectives

Elevated circulating branched-chain amino acids (BCAAs) have been associated with obesity, insulin resistance, and MASLD. Nonetheless, BCAA supplementation has been shown to provide protective outcomes towards the intervention of MASLD. Currently, there is a lack of study towards the contribution of the BCAA: valine on MASLD. Herein, the effect of low-dose valine supplementation was investigated for its role in the progression of MASLD.

Methods

C57BL/6J mice were fed a high-fat/high-cholesterol diet (HFD) to induce MASLD. Upon the establishment of MASLD, valine was supplemented via voluntary oral administration. Clinical and biochemical parameters associated with MASLD were measured, and molecular mechanism and gut microbiota modulation from the effect of valine were investigated.

Results

Low-dose valine was found to attenuate the progression of MASLD, significantly reducing the gain in body weight, liver weight, and epididymal white adipose tissue (eWAT) weight, while also attenuating hyperglycemia and hyperleptinemia, and improving serum lipid profiles. Mechanistically, in the liver, genes related to hepatic lipogenesis and cholesterol biosynthesis were downregulated, while those associated with fatty acid oxidation, autophagy, and antioxidant capacity were upregulated, and AMPK pathway activity was enhanced. Liver and hypothalamic leptin resistance and inflammation were also attenuated, allowing better appetite control in mice fed a HFD and leading to reduced food intake. Additionally, metabolic flexibility in the eWAT was improved, and the gut microbiome was modulated by low-dose valine supplementation.

Conclusion

Low-dose valine supplementation attenuates MASLD by enhancing systemic leptin sensitivity and modulating the gut microbiome.
循环支链氨基酸(BCAA)的升高与肥胖、胰岛素抵抗和MASLD有关,但补充BCAA已被证明对干预MASLD具有保护作用。目前,关于 BCAA(缬氨酸)对 MASLD 的影响还缺乏研究。本研究调查了在高脂/高胆固醇饮食(HFD)模型中补充低剂量缬氨酸对 MASLD 的影响。研究发现,低剂量缬氨酸可减轻 MASLD 的进展,显著降低体重、肝脏重量和 eWAT 重量,减轻高血糖症状并改善血清脂质状况。它还能降低高瘦素血症,增强下丘脑瘦素敏感性,从而减少食物摄入量。在 eWAT 中,脂肪生成相关基因表达上调,瘦素表达受到抑制,这表明代谢灵活性得到改善。在肝脏中,缬氨酸改善了肝脏瘦素敏感性,减轻了肝脏脂肪变性,降低了甘油三酯、胆固醇、TNFα和IL-6水平。从机理上讲,缬氨酸能提高肝脏抗氧化能力,调节脂质代谢和抗氧化途径,下调新生脂肪生成和胆固醇合成,同时增加脂肪酸氧化和自噬相关基因的表达。此外,肝脏 AMPK 通路的活性也得到了增强,有助于改善瘦素敏感性和信号传导。此外,低剂量缬氨酸补充剂还能调节肠道微生物组,这表明有一种多方面的方法可以控制 MASLD。
{"title":"Low-dose valine attenuates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) in mice by enhancing leptin sensitivity and modulating the gut microbiome","authors":"Felicianna ,&nbsp;Emily K.K. Lo ,&nbsp;Congjia Chen ,&nbsp;Marsena J. Ismaiah ,&nbsp;Fangfei Zhang ,&nbsp;Hoi Kit Matthew Leung ,&nbsp;Hani El-Nezami","doi":"10.1016/j.molmet.2024.102059","DOIUrl":"10.1016/j.molmet.2024.102059","url":null,"abstract":"<div><h3>Objectives</h3><div>Elevated circulating branched-chain amino acids (BCAAs) have been associated with obesity, insulin resistance, and MASLD. Nonetheless, BCAA supplementation has been shown to provide protective outcomes towards the intervention of MASLD. Currently, there is a lack of study towards the contribution of the BCAA: valine on MASLD. Herein, the effect of low-dose valine supplementation was investigated for its role in the progression of MASLD.</div></div><div><h3>Methods</h3><div>C57BL/6J mice were fed a high-fat/high-cholesterol diet (HFD) to induce MASLD. Upon the establishment of MASLD, valine was supplemented via voluntary oral administration. Clinical and biochemical parameters associated with MASLD were measured, and molecular mechanism and gut microbiota modulation from the effect of valine were investigated.</div></div><div><h3>Results</h3><div>Low-dose valine was found to attenuate the progression of MASLD, significantly reducing the gain in body weight, liver weight, and epididymal white adipose tissue (eWAT) weight, while also attenuating hyperglycemia and hyperleptinemia, and improving serum lipid profiles. Mechanistically, in the liver, genes related to hepatic lipogenesis and cholesterol biosynthesis were downregulated, while those associated with fatty acid oxidation, autophagy, and antioxidant capacity were upregulated, and AMPK pathway activity was enhanced. Liver and hypothalamic leptin resistance and inflammation were also attenuated, allowing better appetite control in mice fed a HFD and leading to reduced food intake. Additionally, metabolic flexibility in the eWAT was improved, and the gut microbiome was modulated by low-dose valine supplementation.</div></div><div><h3>Conclusion</h3><div>Low-dose valine supplementation attenuates MASLD by enhancing systemic leptin sensitivity and modulating the gut microbiome.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102059"},"PeriodicalIF":7.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-omics after O-GlcNAc alteration identified cellular processes promoting aneuploidy after loss of O-GlcNAc transferase O-GlcNAc改变后的多重形态学发现了O-GlcNAc转移酶缺失后促进非整倍体的细胞过程。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-29 DOI: 10.1016/j.molmet.2024.102060
Samuel S. Boyd , Dakota R. Robarts , Khue Nguyen , Maite Villar , Ibtihal M. Alghusen , Manasi Kotulkar , Aspin Denson , Halyna Fedosyuk , Stephen A. Whelan , Norman C.Y. Lee , John Hanover , Wagner B. Dias , Ee Phie Tan , Steven R. McGreal , Antonio Artigues , Russell H. Swerdlow , Jeffrey A. Thompson , Udayan Apte , Chad Slawson

Objective

Pharmacologic or genetic manipulation of O-GlcNAcylation, an intracellular, single sugar post-translational modification, are difficult to interpret due to the pleotropic nature of O-GlcNAc and the vast signaling pathways it regulates.

Method

To address the pleotropic nature of O-GlcNAc, we employed either OGT (O-GlcNAc transferase), OGA (O-GlcNAcase) liver knockouts, or pharmacological inhibition of OGA coupled with multi-Omics analysis and bioinformatics.

Results

We identified numerous genes, proteins, phospho-proteins, or metabolites that were either inversely or equivalently changed between conditions. Moreover, we identified pathways in OGT knockout samples associated with increased aneuploidy. To test and validate these pathways, we induced liver growth in OGT knockouts by partial hepatectomy. OGT knockout livers showed a robust aneuploidy phenotype with disruptions in mitosis, nutrient sensing, protein metabolism/amino acid metabolism, stress response, and HIPPO signaling demonstrating how OGT is essential in controlling aneuploidy pathways.

Conclusion

These data show how a multi-Omics platform can disentangle the pleotropic nature of O-GlcNAc to discern how OGT fine-tunes multiple cellular pathways involved in aneuploidy.
O-GlcNAcylation是一种细胞内的单糖翻译后修饰,由于O-GlcNAc的多向性及其调控的信号通路广泛,因此很难对其进行药物或遗传操作。为了解决这个问题,我们采用了OGT(O-GlcNAc转移酶)、OGA(O-GlcNAcase)肝脏基因敲除或药理抑制OGA的方法,并结合了多重组学分析和生物信息学。我们发现了许多基因、蛋白质、磷酸蛋白或代谢物在不同条件下发生了反向或等效变化。此外,我们还在 OGT 基因敲除样本中发现了与非整倍体增加相关的通路。为了测试和验证这些通路,我们通过部分肝切除术诱导 OGT 基因敲除者的肝脏生长。OGT基因敲除的肝脏表现出强大的非整倍体表型,有丝分裂、营养传感、蛋白质代谢/氨基酸代谢、应激反应和HIPPO信号转导均出现紊乱,这表明OGT在控制非整倍体途径中至关重要。此外,这些数据还显示了多重分子生物学平台如何能够辨别 OGT 如何微调非整倍体所涉及的多种细胞通路。
{"title":"Multi-omics after O-GlcNAc alteration identified cellular processes promoting aneuploidy after loss of O-GlcNAc transferase","authors":"Samuel S. Boyd ,&nbsp;Dakota R. Robarts ,&nbsp;Khue Nguyen ,&nbsp;Maite Villar ,&nbsp;Ibtihal M. Alghusen ,&nbsp;Manasi Kotulkar ,&nbsp;Aspin Denson ,&nbsp;Halyna Fedosyuk ,&nbsp;Stephen A. Whelan ,&nbsp;Norman C.Y. Lee ,&nbsp;John Hanover ,&nbsp;Wagner B. Dias ,&nbsp;Ee Phie Tan ,&nbsp;Steven R. McGreal ,&nbsp;Antonio Artigues ,&nbsp;Russell H. Swerdlow ,&nbsp;Jeffrey A. Thompson ,&nbsp;Udayan Apte ,&nbsp;Chad Slawson","doi":"10.1016/j.molmet.2024.102060","DOIUrl":"10.1016/j.molmet.2024.102060","url":null,"abstract":"<div><h3>Objective</h3><div>Pharmacologic or genetic manipulation of O-GlcNAcylation, an intracellular, single sugar post-translational modification, are difficult to interpret due to the pleotropic nature of O-GlcNAc and the vast signaling pathways it regulates.</div></div><div><h3>Method</h3><div>To address the pleotropic nature of O-GlcNAc, we employed either OGT (O-GlcNAc transferase), OGA (O-GlcNAcase) liver knockouts, or pharmacological inhibition of OGA coupled with multi-Omics analysis and bioinformatics.</div></div><div><h3>Results</h3><div>We identified numerous genes, proteins, phospho-proteins, or metabolites that were either inversely or equivalently changed between conditions. Moreover, we identified pathways in OGT knockout samples associated with increased aneuploidy. To test and validate these pathways, we induced liver growth in OGT knockouts by partial hepatectomy. OGT knockout livers showed a robust aneuploidy phenotype with disruptions in mitosis, nutrient sensing, protein metabolism/amino acid metabolism, stress response, and HIPPO signaling demonstrating how OGT is essential in controlling aneuploidy pathways.</div></div><div><h3>Conclusion</h3><div>These data show how a multi-Omics platform can disentangle the pleotropic nature of O-GlcNAc to discern how OGT fine-tunes multiple cellular pathways involved in aneuploidy.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102060"},"PeriodicalIF":7.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes 甲状腺激素受体 beta(THRβ1)是人类 iPSC 衍生肝细胞中 T3 作用的主要调节因子。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-29 DOI: 10.1016/j.molmet.2024.102057
Lorraine Soares De Oliveira , Joseph E. Kaserman , Anne H. Van Der Spek , Nora J. Lee , Hendrik J. Undeutsch , Rhiannon B. Werder , Andrew A. Wilson , Anthony N. Hollenberg

Objective

Thyroid hormone (TH) action is mediated by thyroid hormone receptor (THR) isoforms. While THRβ1 is likely the main isoform expressed in liver, its role in human hepatocytes is not fully understood.

Methods

To elucidate the role of THRβ1 action in human hepatocytes we used CRISPR/Cas9 editing to knock out THRβ1 in induced pluripotent stem cells (iPSC). Following directed differentiation to the hepatic lineage, iPSC-derived hepatocytes were then interrogated to determine the role of THRβ1 in ligand-independent and -dependent functions.

Results

We found that the loss of THRβ1 promoted alterations in proliferation rate and metabolic pathways regulated by T3, including gluconeogenesis, lipid oxidation, fatty acid synthesis, and fatty acid uptake. We observed that key genes involved in liver metabolism are regulated through both T3 ligand-dependent and -independent THRβ1 signaling mechanisms. Finally, we demonstrate that following THRβ1 knockout, several key metabolic genes remain T3 responsive suggesting they are THRα targets.

Conclusions

These results highlight that iPSC-derived hepatocytes are an effective platform to study mechanisms regulating TH signaling in human hepatocytes.
目的:甲状腺激素(TH)的作用是由甲状腺激素受体(THR)同工酶介导的。虽然 THRβ1 可能是肝脏中表达的主要同工酶,但其在人类肝细胞中的作用尚未完全明了:为了阐明THRβ1在人类肝细胞中的作用,我们使用CRISPR/Cas9编辑技术敲除诱导多能干细胞(iPSC)中的THRβ1。在定向分化为肝系后,我们对 iPSC 衍生的肝细胞进行了检测,以确定 THRβ1 在配体依赖性和配体依赖性功能中的作用:结果:我们发现,THRβ1的缺失促进了增殖率和受T3调控的代谢途径的改变,包括葡萄糖生成、脂质氧化、脂肪酸合成和脂肪酸摄取。我们观察到,参与肝脏代谢的关键基因通过依赖于 T3 配体和不依赖于 THRβ1 的信号机制进行调控。最后,我们证明了在THRβ1基因敲除后,几个关键的代谢基因仍然对T3有反应,这表明它们是THRα的靶标:这些结果突出表明,iPSC 衍生的肝细胞是研究人类肝细胞中 TH 信号调节机制的有效平台。
{"title":"Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes","authors":"Lorraine Soares De Oliveira ,&nbsp;Joseph E. Kaserman ,&nbsp;Anne H. Van Der Spek ,&nbsp;Nora J. Lee ,&nbsp;Hendrik J. Undeutsch ,&nbsp;Rhiannon B. Werder ,&nbsp;Andrew A. Wilson ,&nbsp;Anthony N. Hollenberg","doi":"10.1016/j.molmet.2024.102057","DOIUrl":"10.1016/j.molmet.2024.102057","url":null,"abstract":"<div><h3>Objective</h3><div>Thyroid hormone (TH) action is mediated by thyroid hormone receptor (THR) isoforms. While THRβ1 is likely the main isoform expressed in liver, its role in human hepatocytes is not fully understood.</div></div><div><h3>Methods</h3><div>To elucidate the role of THRβ1 action in human hepatocytes we used CRISPR/Cas9 editing to knock out THRβ1 in induced pluripotent stem cells (iPSC). Following directed differentiation to the hepatic lineage, iPSC-derived hepatocytes were then interrogated to determine the role of THRβ1 in ligand-independent and -dependent functions.</div></div><div><h3>Results</h3><div>We found that the loss of THRβ1 promoted alterations in proliferation rate and metabolic pathways regulated by T3, including gluconeogenesis, lipid oxidation, fatty acid synthesis, and fatty acid uptake. We observed that key genes involved in liver metabolism are regulated through both T3 ligand-dependent and -independent THRβ1 signaling mechanisms. Finally, we demonstrate that following THRβ1 knockout, several key metabolic genes remain T3 responsive suggesting they are THRα targets.</div></div><div><h3>Conclusions</h3><div>These results highlight that iPSC-derived hepatocytes are an effective platform to study mechanisms regulating TH signaling in human hepatocytes.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102057"},"PeriodicalIF":7.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNA-binding protein YBX3 promotes PPARγ-SLC3A2 mediated BCAA metabolism fueling brown adipogenesis and thermogenesis RNA结合蛋白YBX3促进PPARγ-SLC3A2介导的BCAA代谢,促进棕色脂肪生成和产热。
IF 7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-29 DOI: 10.1016/j.molmet.2024.102053
Lin-Yun Chen , Li-Wen Wang , Jie Wen , Jing-Dong Cao , Rui Zhou , Jin-Lin Yang , Ye Xiao , Tian Su , Yan Huang , Qi Guo , Hai-Yan Zhou , Xiang-Hang Luo , Xu Feng

Objective

Activating brown adipose tissue (BAT) thermogenesis is a promising approach to combat obesity and metabolic disorders. The post-transcriptional regulation of BAT thermogenesis mediated by RNA-binding proteins (RBPs) is still not fully understood. This study explores the physiological role of novel RBPs in BAT differentiation and thermogenesis.

Methods

We used multiple public datasets to screen out novel RBPs responsible for BAT differentiation and thermogenesis. In vitro loss- and gain-of-function experiments were performed in both C3H10T1/2 preadipocytes and mature brown adipocytes to determine the role of Y-box binding protein 3 (YBX3) in brown adipocyte differentiation and thermogenesis. Adeno-associated virus (AAV)-mediated BAT-specific knockdown or overexpression of Ybx3 was applied to investigate the function of YBX3 in vivo.

Results

YBX3 is a brown adipocyte-enriched RBP induced by cold stimulation and β-adrenergic signaling. Both in vitro loss- and gain-of-function experiments demonstrate that YBX3 is essential for brown adipocyte differentiation and thermogenesis. BAT-specific loss of Ybx3 dampens thermogenesis and exacerbates diet-induced obesity in mice, while overexpression of Ybx3 promotes thermogenesis and confers protection against diet-induced metabolic dysfunction. Transcriptome analysis and mitochondrial stress test indicate that Ybx3 deficiency compromises the mitochondrial oxidative phosphorylation, leading to thermogenic failure. Mechanistically, YBX3 stabilizes the mRNA of Slc3a2 and Pparg, which facilitates branched-chain amino acid (BCAA) influx and catabolism and fuels brown adipocyte differentiation and thermogenesis.

Conclusions

YBX3 facilitates BAT fueling BCAA to boost thermogenesis and energy expenditure, which protects against obesity and metabolic dysfunction. Thus, YBX3 could be a promising therapeutic target for obesity.
目的:激活棕色脂肪组织(BAT)的产热是对抗肥胖和代谢紊乱的一种很有前景的方法。由 RNA 结合蛋白(RBPs)介导的 BAT 产热的转录后调控尚未完全明了。本研究探讨了新型 RBPs 在 BAT 分化和产热过程中的生理作用:方法:我们利用多个公开数据集筛选出负责 BAT 分化和产热的新型 RBPs。我们在C3H10T1/2前脂肪细胞和成熟棕色脂肪细胞中进行了体外功能缺失和功能增益实验,以确定Y-盒结合蛋白3(YBX3)在棕色脂肪细胞分化和产热中的作用。应用腺相关病毒(AAV)介导的BAT特异性Ybx3敲除或过表达研究了YBX3在体内的功能:结果:YBX3是一种富含棕色脂肪细胞的RBP,由冷刺激和β肾上腺素能信号诱导。体外功能缺失和功能增益实验均证明,YBX3 对棕色脂肪细胞的分化和产热至关重要。BAT特异性缺失Ybx3会抑制小鼠的产热并加剧饮食诱导的肥胖,而过表达Ybx3则会促进产热并防止饮食诱导的代谢功能障碍。转录组分析和线粒体压力测试表明,Ybx3 缺乏会损害线粒体氧化磷酸化,导致产热失败。从机制上讲,YBX3能稳定Slc3a2和Pparg的mRNA,从而促进支链氨基酸(BCAA)的流入和分解,并促进棕色脂肪细胞的分化和产热:结论:YBX3 可促进 BAT 为 BCAA 提供燃料,从而促进产热和能量消耗,防止肥胖和代谢功能障碍。因此,YBX3 可作为肥胖症的治疗靶点。
{"title":"RNA-binding protein YBX3 promotes PPARγ-SLC3A2 mediated BCAA metabolism fueling brown adipogenesis and thermogenesis","authors":"Lin-Yun Chen ,&nbsp;Li-Wen Wang ,&nbsp;Jie Wen ,&nbsp;Jing-Dong Cao ,&nbsp;Rui Zhou ,&nbsp;Jin-Lin Yang ,&nbsp;Ye Xiao ,&nbsp;Tian Su ,&nbsp;Yan Huang ,&nbsp;Qi Guo ,&nbsp;Hai-Yan Zhou ,&nbsp;Xiang-Hang Luo ,&nbsp;Xu Feng","doi":"10.1016/j.molmet.2024.102053","DOIUrl":"10.1016/j.molmet.2024.102053","url":null,"abstract":"<div><h3>Objective</h3><div>Activating brown adipose tissue (BAT) thermogenesis is a promising approach to combat obesity and metabolic disorders. The post-transcriptional regulation of BAT thermogenesis mediated by RNA-binding proteins (RBPs) is still not fully understood. This study explores the physiological role of novel RBPs in BAT differentiation and thermogenesis.</div></div><div><h3>Methods</h3><div>We used multiple public datasets to screen out novel RBPs responsible for BAT differentiation and thermogenesis. In vitro loss- and gain-of-function experiments were performed in both C3H10T1/2 preadipocytes and mature brown adipocytes to determine the role of Y-box binding protein 3 (YBX3) in brown adipocyte differentiation and thermogenesis. Adeno-associated virus (AAV)-mediated BAT-specific knockdown or overexpression of <em>Ybx3</em> was applied to investigate the function of YBX3 <em>in vivo</em>.</div></div><div><h3>Results</h3><div>YBX3 is a brown adipocyte-enriched RBP induced by cold stimulation and β-adrenergic signaling. Both <em>in vitro</em> loss- and gain-of-function experiments demonstrate that YBX3 is essential for brown adipocyte differentiation and thermogenesis. BAT-specific loss of <em>Ybx3</em> dampens thermogenesis and exacerbates diet-induced obesity in mice, while overexpression of <em>Ybx3</em> promotes thermogenesis and confers protection against diet-induced metabolic dysfunction. Transcriptome analysis and mitochondrial stress test indicate that <em>Ybx3</em> deficiency compromises the mitochondrial oxidative phosphorylation, leading to thermogenic failure. Mechanistically, YBX3 stabilizes the mRNA of <em>Slc3a2</em> and <em>Pparg</em>, which facilitates branched-chain amino acid (BCAA) influx and catabolism and fuels brown adipocyte differentiation and thermogenesis.</div></div><div><h3>Conclusions</h3><div>YBX3 facilitates BAT fueling BCAA to boost thermogenesis and energy expenditure, which protects against obesity and metabolic dysfunction. Thus, YBX3 could be a promising therapeutic target for obesity.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"90 ","pages":"Article 102053"},"PeriodicalIF":7.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1